Autoimmune Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

An Open-label Study of Povetacicept (ALPN-303) in Autoimmune Kidney Diseases.
Conditions:   Lupus Nephritis;   Immunoglobulin A Nephropathy;   Membranous Nephropathy Intervention:   Drug: povetacicept Sponsor:   Alpine Immune Sciences, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2023 Category: Research Source Type: clinical trials

An Open-label Study of Povetacicept (ALPN-303) in Autoimmune Kidney Diseases
Conditions:   Lupus Nephritis;   Immunoglobulin A Nephropathy;   Membranous Nephropathy Intervention:   Drug: povetacicept Sponsor:   Alpine Immune Sciences, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2023 Category: Research Source Type: clinical trials